IperionX Limited(IPX)Earnings, Financials & Key Ratios
IPX•NASDAQ
$37.75
$1.27B mkt cap·Price updated May 6, 2026
AboutIperionX Limited engages in the exploration and development of mineral properties. It explores for epithermal and replacement style precious and base metal mineralization, as well as titanium, rare earth elements, silica sand, and zircon minerals. The company holds a 100% interest in the Milford project that includes 101 claims located in Utah, the United States. It also holds a 100% interest in Titan project covering an area of approximately 6,000 acres situated in Tennessee, the United States. The company was formerly known as Hyperion Metals Limited and changed its name to IperionX Limited in February 2022. IperionX Limited was incorporated in 2017 and is headquartered in Charlotte, North Carolina.Show more
- Revenue$0
- EBITDA-$38M-69.2%
- Net Income-$35M-59.0%
- EPS (Diluted)-1.20-20.0%
- ROE-49.17%+20.5%
- ROIC-96.2%+16.4%
- Debt/Equity0.04+46.6%
- Interest Coverage-128.45
IPX Key Insights
IperionX Limited (IPX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
✗Weaknesses
- ✗Weak Piotroski F-Score: 2/9
- ✗Weak momentum: RS Rating 15 (bottom 15%)
- ✗Shares diluted 35.2% in last year
- ✗Trading more than 30% below 52-week high
- ✗Expensive at 12.0x book value
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
IPX Price & Volume
IperionX Limited (IPX) stock price & volume — 10-year historical chart
Loading chart...
IPX Growth Metrics
IperionX Limited (IPX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-360756.73%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-
Return on Capital
10 Years-143.1%
5 Years-213.2%
3 Years-78.55%
Last Year-52.72%
IPX Recent Earnings
IperionX Limited (IPX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 6/12 qtrs (60%)
Q2 2026Latest
Mar 12, 2026EPS
$0.10
Est $0.04
-150.0%
Revenue
—
Est $4M
Q4 2025
Oct 3, 2025EPS
$1.20
Est $0.05
-2298.9%
Revenue
—
Est $1M
Q4 2025
Sep 30, 2025EPS
$1.20
Est $0.05
-2298.9%
Revenue
—
Est $1M
Q2 2025
Mar 13, 2025EPS
$0.00
Est $0.09
+99.3%
Revenue
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 12, 2026 | $0.10vs $0.04-150.0% | —vs $4M |
| Q4 2025 | Oct 3, 2025 | $1.20vs $0.05-2298.9% | —vs $1M |
| Q4 2025 | Sep 30, 2025 | $1.20vs $0.05-2298.9% | —vs $1M |
| Q2 2025 | Mar 13, 2025 | $0.00vs $0.09+99.3% | — |
Based on last 12 quarters of dataView full earnings history →
IPX Peer Comparison
IperionX Limited (IPX) competitors in Specialty and Advanced Materials — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 TPVG | 225.54M | 5.57 | 4.57 | 36.55% | 13.09% | 1.33 | ||
 ATLX | 122.06M | 5.60 | -1.92 | -180.69% | -91.66% | 0.47 | ||
 AMTX | 220.79M | 3.24 | -2.53 | -22.29% | -38.96% | |||
 ATI | 22.61B | 165.08 | 57.92 | 5.16% | 9.26% | 22.73% | 1.02 | |
 CRS | 22.76B | 458.16 | 61.75 | 4.25% | 15.82% | 24.41% | 0.39 | |
 KALU | 2.92B | 180.42 | 26.65 | 11.54% | 4.14% | 18.68% | 1.36 | |
 CENX | 5.85B | 62.62 | 19.03 | 1.6% | 3.37% | 12.22% | 0.78 | |
 BA | 181.25B | 229.93 | 92.71 | 34.49% | 2.46% | 289.7% | 9.97 |
Compare IPX vs Peers
IperionX Limited (IPX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IPX Income Statement
IperionX Limited (IPX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 0 | 0 | 22.73K | 9.38K | 152.9K | 634.11K | 648.22K | 2.27M | 2.63M |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0▲ 0% | 0▲ 0% | 0▲ 0% | -22.73K▲ 0% | -9.38K▲ 58.7% | -152.9K▼ 1529.4% | -634.11K▼ 314.7% | -648.22K▼ 2.2% | -2.27M▼ 250.9% | -4.58M▲ 0% |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | 58.72% | -1529.41% | -314.71% | -2.22% | -250.87% | - |
| Operating Expenses | 73.55K | 711.26K | 398.37K | 381.53K | 8.11M | 21.87M | 25.62M | 22.36M | 38.28M | 51.41M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 73.55K | 711.26K | 398.37K | 365.91K | 8.11M | 11.4M | 17.3M | 13.49M | 25.53M | 50.44M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 180.19K | 1.08M | 8.33M | 8.87M | 12.75M | 23.56M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 15.62K | -180.19K | 9.39M | 0 | 0 | 0 | 0 |
| Operating Income | -73.56K▲ 0% | -711.26K▼ 867.0% | -398.37K▲ 44.0% | -352.96K▲ 11.4% | -8.12M▼ 2199.8% | -21.85M▼ 169.2% | -17.66M▲ 19.2% | -22.46M▼ 27.2% | -39.27M▼ 74.9% | -75.88M▲ 0% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | - | -866.97% | 43.99% | 11.4% | -2199.79% | -169.21% | 19.18% | -27.15% | -74.87% | - |
| EBITDA | -33.35K | -592.64K | -278.23K | -330.23K | -8.12M | -21.7M | -17.24M | -22.33M | -37.79M | -72.44M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | - | -1676.77% | 53.05% | -18.69% | -2357.79% | -167.36% | 20.57% | -29.58% | -69.21% | -609.23% |
| D&A (Non-Cash Add-back) | 40.2K | 118.61K | 120.14K | 22.73K | 1.05K | 153.43K | 426.53K | 124.75K | 1.48M | 3.44M |
| EBIT | -96.09K | -1.31M | -769.63K | -741.34K | -8.12M | -21.87M | -17.58M | -22.62M | -39.27M | -75.95M |
| Net Interest Income | 0 | 0 | 0 | 11.98K | -2.42K | -21.5K | 76.65K | 645.97K | 1.89M | 3.37M |
| Interest Income | 0 | 1.62K | 21.58K | 15.18K | 5.09K | 24.04K | 207.68K | 555.59K | 2.2M | 3.73M |
| Interest Expense | 0 | 0 | 0 | 3.2K | 7.52K | 45.54K | 131.03K | -90.38K | 305.73K | 366.8K |
| Other Income/Expense | 2 | 2.21K | -139.64K | 38.28K | -5.16M | 348.77K | 216.8K | 773.62K | 3.92M | 1.46M |
| Pretax Income | -73.55K▲ 0% | -709.63K▼ 864.8% | -376.79K▲ 46.9% | -355.23K▲ 5.7% | -13.28M▼ 3638.4% | -21.52M▼ 62.1% | -17.44M▲ 18.9% | -21.84M▼ 25.2% | -35.35M▼ 61.8% | -53.97M▲ 0% |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -40.2K | -118.61K | -120.14K | 20.06K | 0 | 0 | 0 | -382.42K | 0 | 0 |
| Effective Tax Rate % | 54.65% | 16.71% | 31.88% | -5.65% | 0% | 0% | 0% | 1.75% | 0% | 0% |
| Net Income | -73.55K▲ 0% | -709.63K▼ 864.8% | -376.79K▲ 46.9% | -355.23K▲ 5.7% | -13.28M▼ 3638.4% | -21.52M▼ 62.1% | -17.44M▲ 18.9% | -22.23M▼ 27.4% | -35.35M▼ 59.0% | -70.18M▲ 0% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | -864.8% | 46.9% | 5.72% | -3638.39% | -62.06% | 18.94% | -27.41% | -59.04% | -360756.73% |
| Net Income (Continuing) | -96.09K | -1.31M | -769.63K | -746.12K | -13.28M | -21.52M | -17.44M | -21.84M | -35.35M | -70.18M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.00▲ 0% | -0.05▼ 1690.0% | -0.03▲ 46.6% | -0.03▲ 5.9% | -0.75▼ 2677.8% | -1.60▼ 113.3% | -1.50▲ 6.3% | -1.00▲ 33.3% | -1.20▼ 20.0% | -20.87▲ 0% |
| EPS Growth % | - | - | 46.55% | 5.92% | -2677.78% | -113.33% | 6.25% | 33.33% | -20% | - |
| EPS (Basic) | -0.00 | -0.05 | -0.03 | -0.03 | -0.75 | -1.60 | -1.50 | -1.00 | -1.20 | - |
| Diluted Shares Outstanding | 23.75M | 13.2M | 13.2M | 13.2M | 13.2M | 13.46M | 16.8M | 21.78M | 29.46M | 3.36M |
| Basic Shares Outstanding | 23.75M | 13.2M | 13.2M | 13.2M | 13.2M | 13.46M | 16.8M | 21.78M | 29.46M | 3.36M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
IPX Balance Sheet
IperionX Limited (IPX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 2.3K | 2.77M | 1.76M | 1.18M | 1.75M | 5.84M | 12.75M | 41.55M | 58.88M | 69.57M |
| Cash & Short-Term Investments | 0 | 2.69M | 1.73M | 1.14M | 1.7M | 5.67M | 11.94M | 33.16M | 54.81M | 65.83M |
| Cash Only | 0 | 2.69M | 1.73M | 1.14M | 1.7M | 5.67M | 11.94M | 33.16M | 54.81M | 65.83M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.3K | 68.11K | 10.62K | 29.22K | 341 | 22.54K | 228.4K | 2.3M | 823.27K | 1.15M |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16.92K | 0 | 425.71K |
| Days Inventory Outstanding | - | - | - | - | - | - | - | 9.53 | - | 15.37 |
| Other Current Assets | 0 | 0 | 0 | 35 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | 11.51K | 425.64K | 758.7K | 864.55K | 1.04M | 4.07M | 10.05M | 13.89M | 46.16M | 59.58M |
| Property, Plant & Equipment | 0 | 0 | 0 | 21.2K | 539.62K | 1.39M | 3.99M | 7.77M | 25.2M | 35.94M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13.55M | 12.91M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 250K | 0 | 0 | 0 | 445.04K |
| Other Non-Current Assets | 11.51K | 425.64K | 758.7K | 843.34K | 504.75K | 2.43M | 6.06M | 6.11M | 7.41M | 30.79M |
| Total Assets | 13.81K▲ 0% | 3.2M▲ 23056.9% | 2.51M▼ 21.4% | 2.05M▼ 18.6% | 2.79M▲ 36.4% | 9.91M▲ 254.9% | 22.8M▲ 130.1% | 55.44M▲ 143.1% | 105.03M▲ 89.5% | 129.16M▲ 0% |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
| Asset Growth % | - | 23056.92% | -21.37% | -18.6% | 36.42% | 254.93% | 130.14% | 143.1% | 89.47% | 484.32% |
| Total Current Liabilities | 85.21K | 188.57K | 47.93K | 65.11K | 637.01K | 2.08M | 1.65M | 3.05M | 8.43M | 17.27M |
| Accounts Payable | 0 | 108.67K | 2.25K | 3.82K | 286.85K | 1.68M | 711.01K | 1.31M | 6M | 5.2M |
| Days Payables Outstanding | - | - | - | 61.35 | 11.16K | 4.01K | 409.26 | 737.11 | 963.55 | 485.33 |
| Short-Term Debt | 50.84K | 0 | 0 | 17.87K | 81.1K | 134.25K | 382.63K | 445.75K | 472.02K | 1.11M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 34.37K | 53.62K | 25.66K | 22.26K | 185.93K | 114.19K | 162.59K | 107.74K | 1.95M | 7.99M |
| Current Ratio | 0.03x | 14.70x | 36.62x | 18.15x | 2.74x | 2.81x | 7.74x | 13.62x | 6.99x | 6.99x |
| Quick Ratio | 0.03x | 14.70x | 36.62x | 18.15x | 2.74x | 2.81x | 7.74x | 13.61x | 6.99x | 6.99x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | -469.96 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 394.55K | 408.78K | 592.69K | 1.04M | 4.16M | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 394.55K | 30.86K | 24.89K | 18.52K | 12.3K | 9.39K |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 394.55K | 377.92K | 567.8K | 1.03M | 3.45M | 11.42M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | -394.55K | 0 | 0 | 0 | 700K | -2.65M |
| Total Liabilities | 85.21K | 188.57K | 47.93K | 65.11K | 1.03M | 2.49M | 2.24M | 4.1M | 12.59M | 0 |
| Total Debt | 50.84K | 0 | 0 | 17.87K | 475.65K | 543.03K | 975.31K | 1.49M | 3.93M | 4.46M |
| Net Debt | 50.84K | -2.69M | -1.73M | -1.12M | -1.22M | -5.13M | -10.96M | -31.67M | -50.88M | -61.37M |
| Debt / Equity | - | - | - | 0.01x | 0.27x | 0.07x | 0.05x | 0.03x | 0.04x | 0.04x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.06x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | 0.85x |
| Interest Coverage | - | - | - | -110.26x | -1079.57x | -479.85x | -134.79x | - | -128.45x | -207.07x |
| Total Equity | -71.4K▲ 0% | 3.01M▲ 4313.4% | 2.47M▼ 18.0% | 1.98M▼ 19.7% | 1.76M▼ 11.2% | 7.42M▲ 321.5% | 20.56M▲ 177.1% | 51.34M▲ 149.7% | 92.44M▲ 80.1% | 108.2M▲ 0% |
| Equity Growth % | - | 4313.43% | -18.03% | -19.66% | -11.16% | 321.55% | 177.14% | 149.67% | 80.06% | 482.01% |
| Book Value per Share | -0.00 | 0.23 | 0.19 | 0.15 | 0.13 | 0.55 | 1.22 | 2.36 | 3.14 | 32.17 |
| Total Shareholders' Equity | -71.4K | 3.01M | 2.47M | 1.98M | 1.76M | 7.42M | 20.56M | 51.34M | 92.44M | 108.2M |
| Common Stock | 2.3K | 3.33M | 3.18M | 3.15M | 10.26M | 29.78M | 58.76M | 112.96M | 197.99M | 243.33M |
| Retained Earnings | -73.7K | -1.04M | -1.53M | -2.01M | -13.23M | -34.75M | -52.2M | -73.88M | -109.23M | -144M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 719.79K | 817.11K | 842.83K | 4.74M | 12.39M | 14M | 12.26M | 3.69M | 8.87M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IPX Cash Flow Statement
IperionX Limited (IPX) cash flow — operating, investing & free cash flow history
| Line item | Jun'17 | Jun'18 | Jun'19 | Jun'20 | Jun'21 | Jun'22 | Jun'23 | Jun'24 | Jun'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 0 | -226 | -503 | -311 | -3.56M | -12.13M | -15.86M | -18.61M | -21.8M | -21.8M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | - | - | -122.24% | 38.13% | -1143959.49% | -241.03% | -30.74% | -17.29% | -17.15% | -114641.19% |
| Net Income | -443 | -971 | -540 | -356 | -13.23M | -21.52M | -17.44M | -21.84K | -35.35M | -70.18M |
| Depreciation & Amortization | 0 | 0 | 0 | 16 | 9.32K | 153.43K | 426.53K | 648.22K | 2.28M | 2.28M |
| Stock-Based Compensation | 0 | 578 | 23 | 43 | 4.08M | 8.34M | 2.59M | 0 | 9.57M | 9.57M |
| Deferred Taxes | 0 | 0 | 0 | -30 | 0 | -377K | -105.92K | 0 | 0 | 0 |
| Other Non-Cash Items | 443 | 237 | -40 | 29 | 5.14M | -2.11K | 1.15K | -19.23M | 582.56K | -13.08M |
| Working Capital Changes | 0 | -69 | 54 | -13 | 437.6K | 1.27M | -1.33M | -2.07K | 1.12M | 1.12M |
| Change in Receivables | 0 | -66 | 54 | -13 | -34.41K | -98.8K | -650.07K | 0 | 1.12M | 1.12M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 0 | -15.72K | -419.87K | -61.98K | 1.76M | -3.07M | -5.71M | -6.53M | -24.28M | -32.53M |
| Capital Expenditures | 0 | -16 | -421 | -3.06K | -66.82K | -1.93M | -2.71M | -8.07M | -17.61M | -22.95M |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | -63 | 0 | 0 | 2.34M | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -15.72K | -419.45K | -58.93K | -513.38K | -889.99K | -3M | 2.04M | -6.67M | -9.59M |
| Cash from Financing | 0 | -329.63K | 100 | -17.14K | 3.5M | 19.39M | 27.89M | 46.59M | 67.99M | 97.45M |
| Debt Issued (Net) | 0 | -183.65K | 0 | 0 | -6.47K | -42.32K | -518.25K | -423.84K | -517.58K | -982.47K |
| Equity Issued (Net) | 0 | 0 | 107.68K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 2M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 186.65K | -107.58K | -17.14K | -85.47K | -430.81K | -1.51M | -172.35K | 116.47K | 245.13K |
| Net Change in Cash | 0▲ 0% | -345.57K▲ 0% | -422.56K▼ 22.3% | -388.95K▲ 8.0% | 1.7M▲ 537.2% | 3.97M▲ 133.8% | 6.27M▲ 57.6% | 21.22M▲ 238.7% | 21.66M▲ 2.1% | 29.34M▲ 0% |
| Free Cash Flow | 0▲ 0% | -242▲ 0% | -924▼ 281.8% | -3.37K▼ 264.6% | -3.62M▼ 107494.0% | -14.06M▼ 287.9% | -18.57M▼ 32.1% | -26.68M▼ 43.7% | -39.41M▼ 47.7% | -54.7M▲ 0% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | - | - | -281.61% | -264.81% | -107487.65% | -287.89% | -32.07% | -43.66% | -47.71% | -862.51% |
| FCF per Share | - | -0.00 | -0.00 | -0.00 | -0.27 | -1.04 | -1.11 | -1.22 | -1.34 | -1.34 |
| FCF Conversion (FCF/Net Income) | - | 0.00x | 0.00x | 0.00x | 0.27x | 0.56x | 0.91x | 0.84x | 0.62x | 0.78x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
IPX Key Ratios
IperionX Limited (IPX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -48.32% | -13.77% | -15.98% | -709.89% | -468.88% | -124.68% | -61.82% | -49.17% | -78.52% |
| Return on Invested Capital (ROIC) | -356.79% | -56.64% | -33.11% | -868.76% | -1159.06% | -222.8% | -115.07% | -96.2% | -96.2% |
| Debt / Equity | - | - | 0.01x | 0.27x | 0.07x | 0.05x | 0.03x | 0.04x | 0.04x |
| Interest Coverage | - | - | -110.26x | -1079.57x | -479.85x | -134.79x | - | -128.45x | -207.07x |
| FCF Conversion | 0.00x | 0.00x | 0.00x | 0.27x | 0.56x | 0.91x | 0.84x | 0.62x | 0.78x |
IPX Frequently Asked Questions
IperionX Limited (IPX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
IperionX Limited (IPX) grew revenue by 0.0% over the past year. Growth has been modest.
IperionX Limited (IPX) reported a net loss of $70.2M for fiscal year 2025.
Dividend & Returns
IperionX Limited (IPX) has a return on equity (ROE) of -49.2%. Negative ROE indicates the company is unprofitable.
IperionX Limited (IPX) had negative free cash flow of $54.7M in fiscal year 2025, likely due to heavy capital investments.
Explore More IPX
IperionX Limited (IPX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates